Background: Patients with preeclampsia display a spectrum of onset time and severity of
clinical presentation, yet the underlying molecular bases for the early-onset and late-onset …

Introduction Preeclampsia is a multisystemic, pregnancy-specific disorder united by new-
onset hypertension but with considerable variation in clinical manifestation, onset, and …

Preeclampsia is a syndromic disease of the mother, fetus, and placenta. The main limitation
in early and accurate diagnosis of preeclampsia is rooted in the heterogeneity of this …

Study design We performed microarray experiments to analyze genome-wide expression
profiling for 10 placentas from pregnant women with preeclampsia and 10 placentas from …

Preeclampsia (PE) is a complex, hypertensive disorder of pregnancy, demonstrating
considerable variability in maternal symptoms and fetal outcomes. Unfortunately, prior …

Early-and late-onset pre-eclampsia (PE) exhibit important clinical differences both regarding
associations to foetal growth restriction as well as short-and long-term health consequences …

Background Preeclampsia is a life-threatening disorder of pregnancy, demonstrating a high
degree of heterogeneity in clinical features such as presentation, disease severity, and …

OBJECTIVE: Candidate genes that are associated with preeclampsia have not been
described fully. We conducted microarray and confirmatory quantitative real time …

The underlying mechanisms behind the obstetric condition pre-eclampsia (PE) are still
unclear. Manifestation of PE is heterogeneous and it has therefore been proposed to be a …

Objectives Pre‐eclampsia is a leading cause of morbidity and mortality during pregnancy.
Although the two forms of this disorder, early‐(EOPE) and late‐onset of pre‐eclampsia …